Investing.com -- Adaptimmune Therapeutics plc (NASDAQ: ADAP) stock plummeted 51% in pre-market trading after the company announced it would sell its cell therapy assets to US WorldMeds for $55 million ...

Since the US Food and Drug Administration (FDA) implemented a ban on ‘compounded’ versions of Wegovy on 22 May, new ...